Drugs / FP253
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00625430 | Mar 2008 → Dec 2012 | prostate cancer | Biotech Equity Partners Pty Ltd | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FP253 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00625430 ↗ |
| Route | Other | “single transrectal intraprostatic injection of FP253” NCT00625430 ↗ |